Maximize product performance by managing risk before, during & after launch with the industry’s most comprehensive global suite of solutions available.
Through our international, industry-leading expertise in Europe & the United States, we work to enhance patient safety & manage the benefit-risk profile.
UBC helps pharmaceutical and biotech manufactures overcome access and adherence challenges by using the right combination of our high-touch services and high-tech solutions. Our patient support programs are powered by UBC Pathways™, our proprietary suite of healthcare analytics and technology solutions.
Obtain regulatory approval through innovative research methods that maximize ROI
Clinical trial management and late stage research to achieve regulatory approval and optimize product commercialization
Almac’s One Unified Clinical Trial Supply Solution has one objective to guarantee the study drug is with the patient at the right time while ensuring the complete chain of custody and minimising wastage of drug from production to destruction.
Up to 60% of clinical development time and 40% of cost are spent on patient recruitment. Data can help, but simply accessing more data only muddies your decision making. With Covance, you get the right analysis on the right data to empower your studies. Recruit eligible patients that fit your protocol faster, identify and secure proven and/or new sites, forecast and measure progress more efficiently. With Covance’s proprietary data, your program hits its mark.
ConneX is a global travel solution providing in-market services and support, designed to meet the unique travel needs of each study, whether it be for rare disease, diverse populations, pediatrics, etc. Our offering removes the burden of complex travel arrangement from site staff, while peace of mind is established for participants, their families and caregivers.
Q2 Solutions can help drive your discovery phase structure activity relationship (SAR) by optimizing for ADME properties, in parallel to your receptor binding potency and selectivity, for more rapid identification of high quality drug candidates.
Navigating the challenges of developing a biosimilar through clinical trials while meeting regulatory guidelines requires an experienced partner. Q2 Solutions offers tailored solutions that will help you make informed decisions and shape validated outcomes for your study, from research to commercialization.
|
|
|
|
|
|
|
|
|